Target intelligence / Profile preview

RNA, U6 small nuclear 551, pseudogene (RNU6-551P)

Target
RNU6-551P
Molecular classification
Pseudogene, Non-coding RNA, Small nuclear RNA derivative
01

Overview

RNU6-551P is a non-coding RNA pseudogene annotated in the human genome derived from the U6 small nuclear RNA (snRNA) gene. The parent U6 snRNA is a highly conserved component of the spliceosome, involved in mRNA intron removal in eukaryotic cells[3][5]. U6 snRNA is essential for splicing function and undergoes several post-transcriptional modifications, but the pseudogene RNU6-551P itself does not encode protein and does not have a demonstrated biological or drug target role. Some pseudogenes, including those of snRNA families, can be transcribed and may function as regulatory RNAs in certain contexts, potentially affecting epigenetic regulation or acting as miRNA decoys, but there is no published evidence of such activity for RNU6-551P specifically[2][4]. There are no known disease links, drug interactions, or clinical biomarker uses for this pseudogene. Clarifying Notes: - The entry is accurate and sufficiently annotated, but it is not a receptor, enzyme, or traditional therapeutic target[1][4]. - Some pseudogenes can affect gene expression or chromatin structure indirectly through RNA-mediated mechanisms[2], but direct involvement or biological functions for RNU6-551P have not been described. - The molecule should not be considered a primary target for drug discovery or disease therapy.

Other names
RNU6-551PRNA, U6 small nuclear 551, pseudogeneENSG00000252470 (Ensembl)106479811 (NCBI Gene)
02

Mechanism of action

None (no drugs target this molecule)

03

Biological functions

Pseudogenes may function as regulatory RNAs, such as competitive endogenous RNAs (ceRNAs) or miRNA decoys; may participate in gene regulation through RNA-mediated mechanisms—but direct function of RNU6-551P is not established
04

Disease associations

None established specifically for RNU6-551P. In general, some pseudogene-derived RNAs may participate in disease by modulating gene expression (e.g., cancer, epigenetic regulation), but this is not demonstrated for RNU6-551P
05

Safety considerations

None (not a therapeutic target; no known toxicity/therapeutic challenges)
06

Interacting drugs

None (no established pharmacological agents targeting this pseudogene)
07

Biomarkers

None established for patient selection or efficacy monitoring associated with RNU6-551P

Beyond the preview

Go deeper on RNA, U6 small nuclear 551, pseudogene (RNU6-551P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 551, pseudogene (RNU6-551P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call